Investigators concluded, “From our data, it is suggested that medical cannabis might be a treatment option for resistant TS patients.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Women were more likely than men to express a preference for edible medical cannabis products and for products with explicit ratios of THC to CBD.
Ninety-six percent of subjects reported symptom relief following cannabis administration. Most participants experienced statistically significant relief within five minutes.
Respondents’ average pain scores fell from 8.4 prior to using medical cannabis to 4.275 afterward.
Federal statistics have identified the suspension of over 72,000 truck drivers as a result of failed drug tests; over half of those failed tests were for marijuana.
Investigators concluded, “Our findings align with epidemiological research on thousands of participants that found no association between cannabis and cardiovascular disease [or] mortality.”
Authors concluded, “There are no instances where the average effect of cannabis is equal to or greater than the driving performance decrements associated with BAC concentration ranging from 0.04 to 0.06 percent.”
Ninety-three percent of respondents said that they lacked adequate knowledge about cannabis’ overall effects, and 97 percent said that they lacked sufficient knowledge regarding which indications it could address.